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Introduction
Sinus histiocytosis with massive lymphadenopathy (SHML)
was first described in 1969 by Rosai and Dorfman [1]. It is a
rare inflammatory disorder with key clinicopathological
characteristics such as emperipolesis and positive immunos-
taining for S-100 protein [2] and CD68. Rosai–Dorfman
disease (RDD) is primarily manifested in the lymph nodes,
yet extranodal disease has been reported in as many as half
of patients [3]. Such cases affect primarily the head and
neck, upper respiratory tract, and central nervous system,
although the disease has been found in almost every organ
system. The gastrointestinal tract is rarely involved, and
only two cases of primary involvement of the pancreas have
been previously described [4, 5].
Case Presentation
We present a 74-year-old African–American female who
presented to another hospital with low-grade periumbilical
pain which she described as “bloating,” but she had experi-
enced no weight loss. Computed tomography of the abdo-
men demonstrated a mass in the head of the pancreas. There
was no radiographic evidence (See Fig. 1) of lymphadenop-
athy or obvious metastatic disease. The mass was located in
the uncinate process and appeared closely adherent to the
superior mesenteric vein (SMV) and superior mesenteric
artery (SMA). The patient denied nausea or vomiting and
was not jaundiced, and her CA 19-9 was within normal
limits. The patient was referred for surgical evaluation. After
review of her imaging and clinical presentation, it was
determined that this mass was suspicious for malignancy.
After discussing options with the patient, she opted for
surgical intervention. The patient underwent a pylorus-
sparing pancreaticoduodenectomy after preoperative medi-
cal evaluation and optimization. Intraoperatively, there was
no evidence of distant spread, and the mass appeared locally
resectable. However, the portal vein was intimately adherent
to the specimen and was resected due to friability and
bleeding. The portal vein was reconstructed in our standard
fashion with primary anastamosis, and the rest of the resec-
tion and reconstruction were uneventful.
Pathologic Findings
The specimen contained a poorly circumscribed mass cen-
tered within the uncinate process of the pancreas and abut-
ting the vascular groove. It was firm and, on cut section,
consisted of yellow–white homogeneous parenchyma. The
greatest dimension measured 2 cm in diameter. The lesion
grossly appeared to infiltrate the wall of the adherent SMV.
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The remaining pancreas was grossly unremarkable without
evidence of additional lesions or disease.
Microscopic Findings
At low magnification, the mass was infiltrative and com-
posed of a polygonal-to-spindle cell population of histio-
cytes (pale areas) and scattered small- to medium-sized
lymphoid aggregates (darker areas). The histiocytes demon-
strated an insidious invasive pattern as they subtly penetrat-
ed and entrapped the surrounding normal pancreatic
elements and extended through the media of the SMA.
The histiocytes had abundant, granular eosinophilic cyto-
plasm with a round-to-oval nucleus. Emperipolesis was
conspicuous and readily identified, particularly within
lymphatic-like spaces (Fig. 2, inset). Immunohistochemical
labeling for CD-68 and S-100 protein (Fig. 3) was diffusely
positive within the histiocytic population confirming the
diagnosis of extranodal Rosai–Dorfman disease. Immune
stain for IgG4 was noncontributory due to high background.
Twelve lymph nodes were also benign.
Discussion
Rosai and Dorfman first described a clinicopathological
entity separate from histiocytosis X in 1969 [1] and named
it SHML. Rosai–Dorfman disease is characterized by
emperipolesis or lymphophagocytosis, where affected nodes
show expansion of the sinuses by histiocytes with an abun-
dant pale eosinophilic cytoplasm often containing lympho-
cytes within. All cases involving the gastrointestinal tract
have strongly expressed CD68 and S-100 protein [2]. Clas-
sically, patients present with painless lymphadenopathy,
which is frequently self-limited in course. The disease
presents in children and young adults though it can affect
all ages. There is a slight predilection for male patients
(58 %) and African–American ethnicity [3]. Its etiology is
yet to be determined, though current thinking attributes it to
an immunologic process.
Occasionally, patients have had an indolent course where
the disease has spread retrograde from the lymph nodes into
other organ systems. Notably, one case report described the
17-year-long course of a patient who presented at 11 years
of age with nasal disease and ultimately died of diffuse
involvement of his lungs, kidneys, and pancreas [6]. Al-
though, the disease was originally defined as a nodal
Fig. 1 Computed tomography demonstrating a subtle mass in the head
of the pancreas, posterior to the portal confluence
Fig. 2 Hematoxylin and eosin-
stained section demonstrating
two distinct cell populations of
polygonal- to spindled-shaped
histiocytes (pale areas) and
scattered lymphoid aggregates
(dark areas). Inset: An area of
lymphocyte engulfment by a
lesional histiocyte consistent
with emperipolesis
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disorder, extranodal involvement has been reported in as
many as half of all patients [3].
Multiple organ systems have been involved in extranodal
disease, notably the head and neck, eyes and orbits, and the
central nervous system. The gastrointestinal system is rarely
involved, and only two cases of primary pancreatic involve-
ment have been reported. Esquivel first reported a 48-year-
old African–American female with a 3.5-cm mass in the
body of the pancreas, who underwent a distal pancreatecto-
my. This patient did not have lymphadenopathy, and preop-
erative biopsies had been inconclusive [5]. Zivin reported a
second case in 2009, a 63-year-old African–American fe-
male with obstructive jaundice and weight loss, who was
found to have a mass in the head of the pancreas. Preoper-
ative fine-needle aspiration was negative for malignancy [5].
It is important to distinguish patients with RDD from
those with autoimmune pancreatitis (AP). In addition to
chronic pancreatitis, the characteristic histologic features of
AP are dense lymphoplasmacytic infiltrate centered on the
pancreatic ducts, venulitis, and interstitial fibrosis. Increased
numbers of IgG4+ plasma cells are also seen in most cases
of AP [7]. The pathologic findings in our patient were
classic for RDD, and the IgG4 stain was noncontributory
due to high background. Furthermore, IgG4+ cells have
been documented in sclerosing diseases, such as AP, but
the association between IgG4+ plasma cells and RDD is not
yet well understood. Two studies evaluating this character-
istic have been reported. In extranodal (pulmonary) RDD,
10–70 % of plasma cells were IgG4+ [7]. In patients with
cutaneous RDD, the mean number of IgG4+ plasma cells
was 349 cells/HPF [8]. This area needs further study in
larger patient populations before conclusions may be drawn
in individual cases.
Patients who present with a pancreas mass, abdominal
discomfort, weight loss, and malaise present a challenge to
clinicians evaluating them for malignant process as this rare
entity may present in an indistinguishable manner. In
patients whose biopsy results are inconclusive or negative
for malignancy despite a clinical picture of neoplasm,
performing immunohistochemical labeling may be a way
to discard RDD from the differential although the vast
majority of patients presenting in such a fashion will have
their diagnosis made upon resection.
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